Works matching IS 10837159 AND DT 2020 AND VI 25 AND IP 8

Results: 30
    1

    ALK‐Rearranged Non‐Small Cell Lung Cancer in 2020: Real‐World Triumphs in an Era of Multigeneration ALK‐Inhibitor Sequencing Informed by Drug Resistance Profiling.

    Published in:
    Oncologist, 2020, v. 25, n. 8, p. 641, doi. 10.1634/theoncologist.2020-0075
    By:
    • Itchins, Malinda;
    • Lau, Brandon;
    • Hudson, Amanda L.;
    • Westman, Helen;
    • Xia, Cathy Yi;
    • Hayes, Sarah A.;
    • Howell, Viive M.;
    • Rodriguez, Michael;
    • Cooper, Wendy A.;
    • Wei, Heng;
    • Buckland, Michael;
    • Li, Bob T.;
    • Li, Mark;
    • Rathi, Vivek;
    • Fox, Stephen B.;
    • Gill, Anthony J.;
    • Clarke, Stephen J.;
    • Boyer, Michael J.;
    • Pavlakis, Nick
    Publication type:
    Article
    2
    3
    4

    Safety and Feasibility of Additional Tumor Debulking to First‐Line Palliative Combination Chemotherapy for Patients with Multiorgan Metastatic Colorectal Cancer.

    Published in:
    Oncologist, 2020, v. 25, n. 8, p. e1195, doi. 10.1634/theoncologist.2019-0693
    By:
    • Gootjes, Elske C.;
    • Stok, Eric P.;
    • Buffart, Tineke E.;
    • Bakkerus, Lotte;
    • Labots, Mariette;
    • Zonderhuis, Barbara M.;
    • Tuynman, Jurriaan B.;
    • Meijerink, Martijn R.;
    • Ven, Peter M.;
    • Haasbeek, Cornelis J.A.;
    • ten Tije, Albert J.;
    • Groot, Jan‐Willem B.;
    • Hendriks, Mathijs P.;
    • Meerten, Esther;
    • Nuyttens, Joost J.M.E.;
    • Grunhagen, Dirk J.;
    • Verhoef, Cornelis;
    • Verheul, Henk M.W.
    Publication type:
    Article
    5
    6
    7
    8

    Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]‐Fluorothymidine Positron Emission Tomography Biomarker Study.

    Published in:
    Oncologist, 2020, v. 25, n. 8, p. e1158, doi. 10.1634/theoncologist.2020-0039
    By:
    • Wesolowski, Robert;
    • Stover, Daniel G.;
    • Lustberg, Maryam B.;
    • Shoben, Abigail;
    • Zhao, Meng;
    • Mrozek, Ewa;
    • Layman, Rachel M.;
    • Macrae, Erin;
    • Duan, Wenrui;
    • Zhang, Jun;
    • Hall, Nathan;
    • Wright, Chadwick L.;
    • Gillespie, Susan;
    • Berger, Michael;
    • Chalmers, Jeffrey J.;
    • Carey, Alahdra;
    • Balasubramanian, Priya;
    • Miller, Brandon L.;
    • Amaya, Peter;
    • Andreopoulou, Eleni
    Publication type:
    Article
    9
    10
    11

    In Reply.

    Published in:
    Oncologist, 2020, v. 25, n. 8, p. e1259, doi. 10.1634/theoncologist.2020-0336
    By:
    • Grande, Enrique;
    • Molina‐Cerrillo, Javier;
    • Alonso‐Gordoa, Teresa
    Publication type:
    Article
    12
    13
    14

    Statin Intolerance, Anti‐HMGCR Antibodies, and Immune Checkpoint Inhibitor‐Associated Myositis: A "Two‐Hit" Autoimmune Toxicity or Clinical Predisposition?

    Published in:
    Oncologist, 2020, v. 25, n. 8, p. e1242, doi. 10.1634/theoncologist.2019-0911
    By:
    • von Itzstein, Mitchell S.;
    • Khan, Shaheen;
    • Popat, Vinita;
    • Lu, Rong;
    • Khan, Saad A.;
    • Fattah, Farjana J.;
    • Park, Jason Y.;
    • Bermas, Bonnie L.;
    • Karp, David R.;
    • Ahmed, Murtaza;
    • Saltarski, Jessica M.;
    • Gloria‐McCutchen, Yvonne;
    • Xie, Yang;
    • Li, Quan‐Zhen;
    • Wakeland, Edward K.;
    • Gerber, David E.
    Publication type:
    Article
    15
    16
    17

    In Reply.

    Published in:
    Oncologist, 2020, v. 25, n. 8, p. e1252, doi. 10.1634/theoncologist.2020-0329
    By:
    • Coomes, Eric A.;
    • Al‐Shamsi, Humaid O.;
    • Meyers, Brandon M.;
    • Alhazzani, Waleed;
    • Alhuraiji, Ahmad;
    • Chemaly, Roy F.;
    • Almuhanna, Meshari;
    • Wolff, Robert A.;
    • Ibrahim, Nuhad K.;
    • Chua, Melvin L.K.;
    • Hotte, Sebastien J.;
    • Elfiki, Tarek;
    • Curigliano, Giuseppe;
    • Eng, Cathy;
    • Grothey, Axel;
    • Xie, Conghua
    Publication type:
    Article
    18
    19

    In Reply.

    Published in:
    Oncologist, 2020, v. 25, n. 8, p. e1255, doi. 10.1634/theoncologist.2020-0119
    By:
    • Raber, Inbar;
    • Peters, Mary Linton;
    • Asnani, Aarti
    Publication type:
    Article
    20
    21

    Association of Programmed Death‐Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase‐Positive Lung Adenocarcinoma Receiving Crizotinib.

    Published in:
    Oncologist, 2020, v. 25, n. 8, p. 702, doi. 10.1634/theoncologist.2020-0088
    By:
    • Yang, Ching‐Yao;
    • Liao, Wei‐Yu;
    • Ho, Chao‐Chi;
    • Chen, Kuan‐Yu;
    • Tsai, Tzu‐Hsiu;
    • Hsu, Chia‐Lin;
    • Liu, Yi‐Nan;
    • Su, Kang‐Yi;
    • Chang, Yih‐Leong;
    • Wu, Chen‐Tu;
    • Liao, Bin‐Chi;
    • Hsu, Chia‐Chi;
    • Hsu, Wei‐Hsun;
    • Lee, Jih‐Hsiang;
    • Lin, Chia‐Chi;
    • Shih, Jin‐Yuan;
    • Yang, James Chih‐Hsin;
    • Yu, Chong‐Jen
    Publication type:
    Article
    22

    Randomized Phase II Study of First‐Line Biweekly Gemcitabine and Carboplatin Versus Biweekly Gemcitabine and Carboplatin plus Maintenance Gemcitabine in Elderly Patients with Untreated Non‐Small Cell Lung Cancer: LOGIK0801.

    Published in:
    Oncologist, 2020, v. 25, n. 8, p. e1146, doi. 10.1634/theoncologist.2020-0322
    By:
    • Takayama, Koichi;
    • Takeshita, Masafumi;
    • Inoue, Koji;
    • Ichiki, Masao;
    • Fujita, Masaki;
    • Harada, Taishi;
    • Shiraishi, Yoshimasa;
    • Wataya, Hiroshi;
    • Tokunaga, Shoji;
    • Yamada, Tadaaki;
    • Uchino, Junji;
    • Sugio, Kenji
    Publication type:
    Article
    23
    24

    Immune‐Related Adverse Events and Immune Checkpoint Inhibitor Efficacy in Patients with Gastrointestinal Cancer with Food and Drug Administration‐Approved Indications for Immunotherapy.

    Published in:
    Oncologist, 2020, v. 25, n. 8, p. 669, doi. 10.1634/theoncologist.2019-0637
    By:
    • Das, Satya;
    • Ciombor, Kristen K.;
    • Haraldsdottir, Sigurdis;
    • Pumpalova, Yoanna;
    • Sahin, Ibrahim H.;
    • Pineda, G.;
    • Shyr, Yu;
    • Lin, E.P.;
    • Hsu, Chih‐Yuan;
    • Chu, Shih‐Kai;
    • Goff, Laura W.;
    • Cardin, Dana B.;
    • Bilen, Mehmet A.;
    • Fisher, George A.;
    • Wu, Christina;
    • Berlin, Jordan
    Publication type:
    Article
    25
    26
    27

    Cardiovascular Outcomes in Relation to Antihypertensive Medication Use in Women with and Without Cancer: Results from the Women's Health Initiative.

    Published in:
    Oncologist, 2020, v. 25, n. 8, p. 712, doi. 10.1634/theoncologist.2019-0977
    By:
    • Reding, Kerryn W.;
    • Aragaki, Aaron K.;
    • Cheng, Richard K.;
    • Barac, Ana;
    • Wassertheil‐Smoller, Sylvia;
    • Chubak, Jessica;
    • Limacher, Marian C.;
    • Hundley, W. Gregory;
    • D'Agostino, Ralph;
    • Vitolins, Mara Z.;
    • Brasky, Theodore M.;
    • Habel, Laurel A.;
    • Chow, Eric J.;
    • Jackson, Rebecca D.;
    • Chen, Chu;
    • Morgenroth, April;
    • Barrington, Wendy E.;
    • Banegas, Matthew;
    • Barnhart, Matthew;
    • Chlebowski, Rowan T.
    Publication type:
    Article
    28

    The MIMIC Study: Prognostic Role and Cutoff Definition of Monocyte‐to‐Lymphocyte Ratio and Lactate Dehydrogenase Levels in Metastatic Colorectal Cancer.

    Published in:
    Oncologist, 2020, v. 25, n. 8, p. 661, doi. 10.1634/theoncologist.2019-0780
    By:
    • Basile, Debora;
    • Garattini, Silvio Ken;
    • Corvaja, Carla;
    • Montico, Marcella;
    • Cortiula, Francesco;
    • Pelizzari, Giacomo;
    • Gerratana, Lorenzo;
    • Audisio, Marco;
    • Lisanti, Camilla;
    • Fanotto, Valentina;
    • Ongaro, Elena;
    • Iacono, Donatella;
    • Cardellino, Giovanni Gerardo;
    • Foltran, Luisa;
    • Pella, Nicoletta;
    • Buonadonna, Angela;
    • Aprile, Giuseppe;
    • Di Maio, Massimo;
    • Fasola, Gianpiero;
    • Puglisi, Fabio
    Publication type:
    Article
    29
    30